Jones Day Fights Ferring's Sanctions Bid Over IP Trial
Law360 (March 26, 2021, 11:20 PM EDT) -- Jones Day shot back Friday against Ferring Pharmaceuticals' bid for sanctions, arguing that the bulk of its accusations, including that the firm "vexatiously" pushed its former client Serenity Pharmaceuticals into a trial, are based on unsubstantiated claims made against the firm by Serenity in a separate lawsuit.
Ferring's sanctions bid "uncritically embraces" Serenity's allegations from the separate state court suit, Jones Day said. The firm previously represented Serenity in its New York federal court dispute with Ferring over an anti-diuretic patent.
Ferring won the counterclaims suit in 2019 and later triumphed in its own suit that resulted in two Serenity patents being...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!